Investigational Site Number :3480002

Pécs 7635

1 studies enrolling now · 6 studies all time

What they study most

Asthma, Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP), Chronic Rhinosinusitis With Nasal Polyps, Myasthenia Gravis, Non-relapsing Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis, Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis

Studies at this site

• A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease. — Recruiting now
• A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis. — Running, not enrolling
• EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients — Completed
• Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis — Stopped early
• Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES) — Completed
• A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal Polyps — Completed